214. The Chairman proposed that the Council revert to this matter later in the course of the present meeting and that, in the meantime, he consult with the delegations most involved in this issue.
215. Following these consultations, the Chairman proposed that the Council adopt the Decision on the "Extension of the Transition Period under Article 66.1 of the TRIPS Agreement for Least-Developed Country Members for Certain Obligations with respect to Pharmaceutical Products" contained in document JOB(02)/123 and approve the revised draft waiver on "Least-Developed Country Members – Obligations under Article 70.9 of the TRIPS Agreement with respect to Pharmaceutical Products" contained in document JOB(02)/57/Rev.14 and agree to forward it to the General Council for adoption. In doing so, he stated that it was understood, in regard to the review foreseen in paragraph 2 of the draft waiver, that the exceptional circumstances justifying this waiver would continue to exist for least-developed country Members until its expiry date of 2016.
